2012Journal of psychiatryRequires access

A comparative study of ziprasidone vs. risperidone in treatment of schizophrenia dominated by negative symptoms

Zhenghua Lin

Open publisher page 0 citations

Abstract

Objective To compare the efficacy and side effects of ziprasidone and risperidone in the treatment of schizophrenia dominated by negative symptoms.Methods 80 schzophrenic inpatients dominated by negative symptoms were randomized into ziprasidone group(40 cases) and risperidone group(40 cases) treated for 8 weeks.The efficacy and side effects were evaluated with Positive and Negative Symptom Scale(PANSS) and Treatment Emergent Symptom Scale(TESS).Results There was no significant difference in efficacy between the two groups(P0.05).However,the incidence rate of side effects in risperidone group was significantly higher than that in ziprasidone group(P0.05).Conclusion Ziprasidone is effective and safe for the treatment of schizophrenia dominated by negative symptoms.

About this research paper

What this paper is about

Objective To compare the efficacy and side effects of ziprasidone and risperidone in the treatment of schizophrenia dominated by negative symptoms.Methods 80 schzophrenic inpatients dominated by negative symptoms were randomized into ziprasidone group(40 cases) and risperidone group(40 cases) treated for 8 weeks.The efficacy and side effects were evaluated with Positive and Negative Symptom Scale(PANSS) and Treatment Emergent Symptom Scale(TESS).Results There was no significant difference in efficacy between the two groups(P0.05).However,the incidence rate of side effects in risperidone group was significantly higher than that in ziprasidone group(P0.05).Conclusion Ziprasidone is effective and safe for the treatment of schizophrenia dominated by negative symptoms.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To compare the efficacy and side effects of ziprasidone and risperidone in the treatment of schizophrenia dominated by negative symptoms.Methods 80 schzophrenic inpatients dominated by negative symptoms were randomized into ziprasidone group(40 cases) and risperidone group(40 cases) treated for 8 weeks.The efficacy and side effects were evaluated with Positive and Negative Symptom Scale(PANSS) and Treatment Emergent Symptom Scale(TESS).Results There was no significant difference in efficacy between the two groups(P0.05).However,the incidence rate of side effects in risperidone group was significantly higher than that in ziprasidone group(P0.05).Conclusion Ziprasidone is effective and safe for the treatment of schizophrenia dominated by negative symptoms.

Key concepts: Ziprasidone, Risperidone, Negative symptom, Schizophrenia (object-oriented programming), Internal medicine, Positive and Negative Syndrome Scale, Side effect (computer science), Psychology

Related papers

Back to paper searchBrowse research topicsOriginal source
A comparative study of ziprasidone vs. risperidone in treatment of schizophrenia dominated by negative symptoms — Research Paper | ScholarLens